Segal Lloyd Mitchell 4
4 · Repare Therapeutics Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Segal Lloyd Mitchell
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2021-06-09$35.00/sh−1,576$55,160→ 96,008 total(indirect: See footnote)
Holdings
- 5,000
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
- [F2]These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.